CN Patent

CN118845788A — 促肾上腺皮质激素释放因子受体拮抗剂

Assigned to Spruce Biosciences Inc · Expires 2024-10-29 · 2y expired

What this patent protects

本发明提供了促肾上腺皮质激素释放因子受体拮抗剂。更具体地，本发明提供了包括‑(4‑氯‑2‑(吗啉‑4‑基)噻唑‑5‑基)‑7‑(l‑乙基丙基)‑2,5‑二甲基吡唑并(l,5‑a)嘧啶的新型药物组合物以及将所述药物组合物用于治疗先天性肾上腺皮质增生症(CAH)的方法。

USPTO Abstract

本发明提供了促肾上腺皮质激素释放因子受体拮抗剂。更具体地，本发明提供了包括‑(4‑氯‑2‑(吗啉‑4‑基)噻唑‑5‑基)‑7‑(l‑乙基丙基)‑2,5‑二甲基吡唑并(l,5‑a)嘧啶的新型药物组合物以及将所述药物组合物用于治疗先天性肾上腺皮质增生症(CAH)的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN118845788A
Jurisdiction
CN
Classification
—
Expires
2024-10-29
Drug substance claim
No
Drug product claim
No
Assignee
Spruce Biosciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.